1. Gastmeir P, Kampf G, Wischnewski N, Hauer T, Schulgen G,Schumacher M,et al. Prevalence of nosocomial infections in representative German hospitals. J Hosp Infect 1998; 38:37-49.
2. Ronald AR, Nicolle LE, Stamm E, Krieger J, Warren J, Schaeffer A, et al. Urinary tract infection in adults: research priorities and strategies. Int J Antimicrob Agents 2001; 17(4):343-8.
3. Loh KY, Sivalingam N. Urinary tract infections in pregnancy. Malaysian Fam Physician 2007; 2: 54-7.
4. Griebling TL. Urologic Diseases in American Project: Trends in Resource Use for Urinary Tract Infections in Women. J Urology2005; 173(4): 1281-7.
5. Schwartz DJ, Kalas V, Pinkner JS, Chen SL, Spaulding CN, Dodson KW, et al. Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation. Proc Natl Acad Sci U S A 2013;110(39):15530-7.
6. Farshad S, Ranjbar R, Japoni A, Hosseini M, Anvarinejad M, Mohammadzadegan R. Microbial susceptibility, virulence factors, and plasmid profiles of uropathogenic Escherichia coli strains isolated from children in Jahrom, Iran. Arch Iran Med 2012;15(5):312–6.
7. Johnson JR, Kuskowski MA, Obryan T, Colodner R, Raz R. Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis. Antimicrob Agents Chemother 2006; 49:26–31.
8. Horcajada JP, Soto S, Gajewski A, Smithson A, Jiménez de Anta MT, Mensa J, et al. Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J Clin Microbiol 2005; 43: 2962-4.
9. Romanus II, Eze AT. Antibiotics susceptibility patterns and clonal relatedness of uropathogenic Escherichia coli in abakaliki, ebonyi state. Canad J Pure Appl Sci 2011; 5(2):1475-79.
10. Farmer JJ. Enterobacteriaceae: Introduction and Identification. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, & R. H. Yolken (Eds.). Manual Clin Microbiol. Washington, D.C.1999:PP 442-50.
11. Tarchouna M, Asma A, Ben-Selma W, Boukadida J. Distribution of uropathogenic virulence genes in Escherichia coli isolated from patients with urinary tract infection. Inter J Infect Dis. 2013; 17: e450–e453.
12. Abiodun AO, Olufunke OA, Dunah FC, Oladiran F. Phenotypic identification and phylogenetic characterization of Uropathogenic Escherichia coli in symptomatic pregnant women with Urinary tract infections in South-Western Nigeria. Int J Biol 2014; 6(4): 145-55.
13. Mbanga J, Mudzana R. Virulence factors and antibiotic resistance patterns of uropathogenic Escherichia coli. African Journal of Microbiology Research 2014; 8(43): 3678-86.10.5897/AJMR2014.7034
14. Derakhshandeh A, Firouzi R, Motamedifar M, Arabshahi S, Novinrooz A, Boroojeni AM, et al. Virulence Characteristics and Antibiotic Resistance Patterns among Various Phylogenetic Groups of Uropathogenic Escherichia coli Isolates. Jpn J Infect Dis 2015; 68:428–31.
15. Usein CR, Damian M, Tatu-Chitoiu D, Capusa C, Fagaras R, Tudorache D, et al. Prevalence of virulence genes in Escherichia coli strains isolated from Romanian adult urinary tract infection cases. J Cell Mol Med2001;5(3):303–10.
16. Le Bouguénec C, Archambaud M, Labigne A. Rapid and specific detection of the pap, afa, and sfa adhesins - encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction, J Clin Microbiol 1992; 30(5): 1189-93.
17. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis2000;181(1):261–72.
18. Le Bougue´nec C, Lalioui L, Du Merle L, Jouve M, courcoux P, Bouzari S, et al. Characterization of AfaE adhesins produced by extraintestinal and intestinal human Escherichia coli isolates. PCR assays for detection of Afa adhesions that do or do not recognize Dr blood group antigens. J Clin Microbiol 2001; 39:1738–45.
19. Bindereif A, Neilands JB. Promoter mapping and transcriptional regulation of the iron assimilation system of plasmid ColV-K30 in Escherichia coli K-12. J Bacteriol 1985; 162:1039–46.
20. Molina-López J, Aparicio-Ozores G, Ribas-Aparicio RM, Gavilanes-Parra S, Chávez-Berrocal ME, Hernández-Castro Ret al. Drug resistance, serotypes, and phylogenetic groups among uropathogenic Escherichia coli including O25-ST131 in Mexico City. J Infect Dev Ctries 2011; 5(12):840-9.
21. Clermont O, Bonacorsis, Bingen E. Rapid and simple determination of Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66: 4555–8.
22. Clermont O, Christenson JK, Denamur E, Gordon DM. The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environmental Microbiology Reports 2013; 5(1):58–65.
23. Alm EW, Walk ST, Gordon DM. The niche of Escherichia coli. In Population Genetics of Bacteria. Walk,S.T., and Feng, P.C.H. (eds). Washington, DC, USA: ASM Press, 2011; 107–23.
24. Crepin S, Houle S, Charbonneau ME, Moures M, Harel J, Dozois CM. Decrease expression of type I fimbriae by a pst mutant of uropathogenic Escherichia coli reduces urinary tract infection. Infect Immun 2012: 80: 2802-15.
25. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nature Reviews Microbiology 2015; 13: 269–84.
26. Munkhdelger Y, Gunregjav N, Dorjpurev A, Juniichiro N, Sarantuya J. Detection of virulence genes, phylogenetic group and antibiotic resistance of uropathogenic Escherichia coli in Mongolia J Infect Dev Ctries 2017;11(1):51-7.
27. Momtaz H, Karimian A, Madani M, Safarpoor Dehkordi F, Ranjbar R, Sarshar M, et al. Uropathogenic Escherichia coli in Iran: serogroup distributions, virulence factors and antimicrobial resistance properties. Ann Clin Microbiol Antimicrob2013; 12:8
28. Karimian A, Momtaz H, Mahbobe Madani M. Detection of uropathogenic Escherichia coli virulence factors in patients with urinary tract infections in Iran. Afr J Microbiol Res 2012; 6(39):6811–6.
29. Wang Y, Zhao Sh, Han L, Guo X, Chen M, Ni Y, et al. Drug resistance and virulence of uropathogenic Escherichia coli from Shanghai, China. The Journal of Antibiotics 2014; 67, 799–805.
30. Paniagua-Contreras GL, Monroy-Pe´rez E, Rodrı´guez-Moctezuma JR, Domı´nguez-Trejo P, Vaca-Paniagua F, Vaca S. Virulence factors, antibiotic resistance phenotypes and O-serogroups of Escherichia coli strains isolated from community-acquired urinary tract infection patients in Mexico. Journal of Microbiology, Immunology and Infection 2015; 1-8. http://dx.doi.org/10.1016/j.jmii.2015.08.005
31. Santo E, Macedo C, Marin JM. Virulence factors of uropathogenic Escherichia coli from a University Hospital in Ribeirão Preto, São Paulo, Brazil. Rev. Inst. Med. trop. S. Paulo 2006; 48(4): 185-8.
32. Rahdar M, Rashki A, Miri HR, Ghalehnoo MR. Detection of pap, sfa, afa, foc, and fim Adhesin-Encoding Operons in Uropathogenic Escherichia coli Isolates Collected From Patients With Urinary Tract Infection.Jundishapur J Microbiol 2015; 8(8):e22647.
33. Alabsi MS, Ghazal A, Sabry SA, Alasaly MM. Association of some virulence genes with antibiotic resistance among uropathogenic Escherichia coli isolated from urinary tract infection patients in Alexandria, Egypt: A hospital-based study. Journal of Global Antimicrobial Resistance 2 2014; 83–6.
34. Bashir S, Haque A, Sawar Y, Ali A, Anwar MI. Virulence profile of different phylogenetic groups of locally isolated community acquired uropathogenic E. coli from Faisalabad region of Pakistan. Annals of Clinical Microbiology and Antimicrobials2012; 11:23https://doi.org/10.1186/1476-0711-11-23
35. Jalali HR, Eslami G, Fallah F, Pourbakhsh A. Genotyping of Virulence Factors of Uropathogenic Escherichia coli by PCR. NovelBiomed. 2015;3(4):177-81.
36. Merza NS, Jubrael JMS. The Prevalence of Virulence Factors Among Uropathogenic Escherichia coli Strains Isolated From Different Hospitals in Kurdistan Region-Iraq. International Journal of Bioinformatics and Biomedical Engineering 2015; 1 (3): 338-43.
37. Ejrnæs K, Stegger M, Reisner A, Ferry S, Monsen T, Stig EH, et al. Characteristics of Escherichia coli causing persistence or relapse of urinary tract infections: Phylogenetic groups, virulence factors and biofilm formation. Virulence 2011; 2(6):528-37. DOI: 10.4161/viru.2.6.18189
38. Lee JH, Subhadra B, Son YJ, Kim DH, Park HS, Kim JM, et al. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea. Letters in Applied Microbiology 2016; 62: 84-90.
39. Garcia TA, Ventura CL, Smith MA, Merrell DS, O’Brien AD. Cytotoxic necrotizing factor 1 and hemolysin from uropathogenic Escherichia coli elicit different host responses in the murine bladder. Infect. Immun 2013; 81, 99–109.
40. Kot B, Wicha J, Gruzewska A, Piechota M, Wolska K, Obrebska M. Virulence factors, biofilm-forming ability, and antimicrobial resistance of urinary Escherichia coli strains isolated from hospitalized patients. Turk J Med Sci 2016; 46:1908-14.
41. Tabasi M, Karam MRA,Habibi M, Mostafavi E, Bouzari S.Genotypic Characterization of Virulence Factors in Escherichia coli Isolated from Patients with Acute Cystitis, Pyelonephritis and Asymptomatic Bacteriuria. Journal of Clinical and Diagnostic Research 2016; 10(12): DC01-DC07.
42. Garenaux A, Caza M, Dozoise CM. The ins and out of siderophore mediated uptake by extra-intestinal pathogenic Escherichia coli. Vet microbiol 2011; 153: 89-98.
43. Iranpour D, Hassanpour M, Ansari H, Tajbakhsh S, Khamisipour G, and Najafi A. Phylogenetic Groups of Escherichia coli Strains from Patients with Urinary Tract Infection in Iran Based on the New Clermont Phylotyping Method. BioMed Research International 2015; 1-7. doi:10.1155/2015/846219
44. Grude N, Potaturkina-Nesterova NI, Jenkins A, Strand L, Nowrouzian FL, Nyhus J, et al. A comparison of phylogenetic group, virulence factors and antibiotic resistance in Russian and Norwegian isolates of Escherichia coli from urinary tract infection. Clin Microbiol Infect 2007; 13: 208-211.
45. Themphachana M, Kongpheng S, Rattanachuay P, Khianngam S, Singkhamanan K, Sukhumungoon P. Molecular characterization of virulence and antimicrobial susceptibility profiles of uropathogenic Escherichia coli from patients in a tertiary hospital, southern Thailand. Southeast Asian J Trop Med PublicHealth2016; 46(6): 1021-30.
46. Gao Q, Zhang D, Ye Z, Zhu X, Yang W, Dong L, et al. Virulence traits and pathogenicity of uropathogenic Escherichia coli isolates with common and uncommon O serotypes. Microbial Pathogenesis 2017; 104: 217e224.
47. Derakhshandeh A, Firouzi R, Moatamedifar M, Motamedi A, Bahadori M, Naziri Z. Phylogenetic analysis of Escherichia coli strains isolated from human samples. Mol Biol Res Commun 2013;2(4):143-9.
48. Johnson JR, Kuskowski MA, Gajewski A, Soto S, Horcajada JP, Jimenez de Anta MT, et al. Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis or prostatitis. J Infect Dis 2005; 191:46-50; PMID:15593002; http://dx.doi.org/10.1086/426450.
49. Yun KW, Kim HY, Park HK, Kim W, Lim IS. Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children. J Microbiol Immun Infect 2014; 47:455-461.
50. Sivick KE, Mobley HL. Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun 2010; 78: 568-585.
51. Bien J, Sokolova O, Bozko P. Role of Uropathogenic Escherichia coli Virulence Factors in Development of Urinary Tract Infection and Kidney Damage. International Journal of Nephrology 2012; 1-15. doi:10.1155/2012/681473.